DALLAS, June 8, 2015 /PRNewswire/ --
Bronchiectasis - Pipeline Review, H1 2015 is the latest market research on therapeutic development for Bronchiectasis treatment providing detailed information and comprehensive coverage of the Bronchiectasis's therapeutic pipeline.
Complete report on Bronchiectasis pipeline review spread across 74 pages, talking about 11 companies and supported with 26 tables and 13 figures is now available at http://www.reportsnreports.com/reports/401446-bronchiectasis-pipeline-review-h1-2015.html .
This report provides comprehensive information on the therapeutic development for Bronchiectasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bronchiectasis and special features on late-stage and discontinued projects.
Companies discussed in this 2015 Bronchiectasis research include Alitair Pharmaceuticals, Inc., Bayer AG, Clarassance, Inc., GlaxoSmithKline plc, Grifols, S.A., Kamada Ltd., Nostrum Pharmaceuticals, LLC, Pulmatrix, Inc., Recipharm AB, Savara Inc. and Serendex Pharmaceuticals A/S . Drug profiles provided in the report cover alpha-1 proteinase inhibitor (human) second generation, ALT-07, ALT-09, ARD-3150, BAY-858501, CG-1011, ciprofloxacin, dapsone, erdosteine, GSK-2793660, Leukotriene B4, levofloxacin, molgramostim, Recombinant Human Follistatin and vancomycin hydrochloride .
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Order a copy of Bronchiectasis - Pipeline Review, H1 2015 market research report at http://www.reportsnreports.com/Purchase.aspx?name=401446 .
The report provides a snapshot of the global therapeutic landscape of Bronchiectasis and reviews key pipeline products under drug profile section which includes product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. It reviews key players involved in the therapeutics development for Bronchiectasis and enlists all their major and minor projects and summarizes all the dormant and discontinued pipeline projects. A review of the Bronchiectasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources is provided along with that of pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Bronchiectasis pipeline on the basis of target, MoA, route of administration and molecule type as well as latest news and deals relating related to pipeline products are provided in this market research report titled Bronchiectasis - Pipeline Review, H1 2015.
Global Markets Direct reports feature investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
On similar lines, ReportsnReports.com offers another research titled Pharmaceutical Preparations for Human Use Acting on the Respiratory System World Report that covers data and information on products and markets like Antihistamines, Bronchial Dilators, Incl. Antiasthamatics & Expectorants, Bronchial: Ethical: Narcotic, Bronchial: Ethical: Nonnarcotic, Cold Preparations: Ethical: Nasal Decongestants, Cold Preparations: Ethical: Antihistamine, Cold Preparations: Ethical: Others, Cold Preparations: Ethical: Proprietry: Decongestants, Cold Preparations: Ethical: Proprietry: Nasal Sprays, Cold Preparations: Ethical: Proprietry: Nose Drops, Cold Preps.: Ethical: Proprietry: Other Decongestants, Cold Preps.: Ethical: Proprietry: Cough Sirups, Cold Preps.: Ethical: Proprietry: Capsules and Tablets, Cold Preps.: Ethical: Proprietry: Lozenges, Cold Preps.: Ethical: Proprietry: Topical Preparations, Cold Preps.: Ethical: Proprietry: Cough Drops, Other Proprietry Cough & Cold Preparations and Other Pharm. Preps. Acting On Respiratory Systems. This Database Covers NAICS Code: P28344_M. Products/Services Classified By 5-Digit US Commerce Department Code and then Defined by Each 6 to 10-Digit Product Codes. It covers historic data for 1997- 2015, forecasts for 2016- 2023 as well as long term projections 2023-2028 with consumption given at industry / distribution channel / service or product line level. 18 products are covered for over 200 countries with information spread across 2084 pages, 10035 spreadsheets, 9770 database tables, 535 diagrams & maps. Order a copy of this Pharmaceutical Preparations for Human Use Acting on the Respiratory System World Report at http://www.reportsnreports.com/Purchase.aspx?name=376787 .
A third research titled Respiratory Measurement Devices - Pipeline Review, 2015 provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key respiratory measurement devices pipeline products. Universities and Companies discussed in this research, along with their pipeline products, include Advanced Circulatory Systems, Inc., Aerocrine AB, Anaxsys Technology Ltd, Arizona State University, Biospeech, Inc., Cambridge Consultants Limited, CAS Medical Systems, Inc., City University London, Dartmouth College, Ecole Polytechnique de Montreal, Feather Sensors, LLC, Flashback Technologies, Inc., Fluorometrix Corporation, GE Global Research, iHealth Lab Inc, Koronis Biomedical Technologies Corporation, Lionsgate Technologies Inc., Masimo Corporation, NanoVation-GS, Neetour Medical Ltd, Nicrem S.r.l., North Carolina State University, Oxitone Medical Ltd, PneumaCare Ltd., Thora-3DI, Princeton University, Sheffield Hallam University, Sparo Labs, Stellenbosch University, Thoracic Medical Systems Inc., Tufts University, University of British Columbia, University of California, Berkeley, University of California, Davis, University of California, San Diego, University of Nebraska Omaha, University of Oxford, University of Washington, Wipox LLC and Xhale, Inc. Read more at http://www.reportsnreports.com/reports/396000-respiratory-measurement-devices-pipeline-review-2015.html .
Explore more reports on the pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+/Google Plus: https://plus.google.com/111656568937629536321/posts
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252